The A640G polymorphism in the NAD(P)H oxidase p22phox gene (CYBA) is associated with risk reduction of coronary heart disease: A meta-analysis

Clinical Biochemistry

Volumn 47, Issue 6, 2014, Pages 409-416

  Liang, Baoyun ^a   Wei, Qiugui ^a   Shen, Tingting ^a   Su, Li ^b   Yan, Yan ^a   Wu, Guangliang ^a   Lu, Jianqi ^a   Gu, Lian ^a  

^a GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

A640G; Coronary heart disease; Meta analysis; NADPH oxidase; P22phox; Polymorphism

Indexed keywords

P22PHOX PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; CYBA PROTEIN, HUMAN;

ARTICLE; CAUCASIAN; CODOMINANCE; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; RISK REDUCTION; SENSITIVITY ANALYSIS; ADULT; AGED; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; ODDS RATIO; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK REDUCTION BEHAVIOR;

EID: 84897113517     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.12.001     Document Type: Article

References (28)

1. Development OfEC-oa Health at a glance 2011: OECD indicators. Health policies and data. Health at a glance 2011.
2. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
3. Weiner S.D., Rabbani L.E. Secondary prevention strategies for coronary heart disease. J Thromb Thrombolysis 2010, 29:8-24.
4. Allender S., Scarborougb P., Peto V., Rayner M. European cardiovascular disease statistics 2008, 2008 ed.
5. Wagner P.D., Viegi G., Luna C.M., Fukuchi Y., Kvale P.A., El Sony A. Major causes of death in China. N Engl J Med 2006, 354:874-876. [author reply-6].
6. Xie F., Qian Q., Chen Z., Ma G., Feng Y. Chitinase 3-like 1 gene-329g/a polymorphism, plasma concentration and risk of coronary heart disease in a Chinese population. Gene 2012, 499:135-138.
7. Zhang X.H., Lu Z.L., Liu L. Coronary heart disease in China. Heart 2008, 94:1126-1131.
8. Mi X., Eskridge K.M., George V., Wang D. Structural equation modeling of gene-environment interactions in coronary heart disease. Ann Hum Genet 2011, 75:255-265.
9. Mohazzab K.M., Kaminski P.M., Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 1994, 266:H2568-H2572.
10. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizaka N., Griendling K.K. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996, 271:23317-23321.
11. Lassegue B., Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003, 285:R277-R297.
12. Griendling K.K. Novel NAD(P)H oxidases in the cardiovascular system. Heart 2004, 90:491-493.
13. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004, 109:227-233.
14. Ago T., Kitazono T., Kuroda J., Kumai Y., Kamouchi M., Ooboshi H., et al. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 2005, 36:1040-1046.
15. Kuroda J., Nakagawa K., Yamasaki T., Nakamura K., Takeya R., Kuribayashi F., et al. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 2005, 10:1139-1151.
16. Wang L. Association of NAD(P)H oxidase p22phox gene A640G mutation and coronary heart disease 2010, Shangdong University, Shandong.
17. Lassegue B., Griendling K.K. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010, 30:653-661.
18. Alexander R.W. Theodore cooper memorial lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995, 25:155-161.
19. Dinauer M.C., Pierce E.A., Bruns G.A., Curnutte J.T., Orkin S.H. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 1990, 86:1729-1737.
20. Gardemann A., Mages P., Katz N., Tillmanns H., Haberbosch W. The p22 phox A640G gene polymorphism but not the c242t gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 1999, 145:315-323.
21. Inoue N., Kawashima S., Kanazawa K., Yamada S., Akita H., Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998, 97:135-137.
22. Goliasch G., Wiesbauer F., Grafl A., Ponweiser E., Blessberger H., Tentzeris I., et al. The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (
23. Zafari A.M., Davidoff M.N., Austin H., Valppu L., Cotsonis G., Lassegue B., et al. The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease. Antioxid Redox Signal 2002, 4:675-680.
24. Macias-Reyes A., Rodriguez-Esparragon F., Caballero-Hidalgo A., Hernandez-Trujillo Y., Medina A., Rodriguez-Perez J.C. Insight into the role of CYBA A640G and C242T gene variants and coronary heart disease risk. A case-control study. Free Radic Res 2008, 42:82-92.
25. Tu Y.C., Ding H., Wang X.J., Xu Y.J., Zhang L., Huang C.X., et al. Exploring epistatic relationships of no biosynthesis pathway genes in susceptibility to CHD. Acta Pharmacol Sin 2010, 31:874-880.
26. Niemiec P., Nowak T., Balcerzyk A., Krauze J., Zak I. The CYBA gene A640G polymorphism influences predispositions to coronary artery disease through interactions with cigarette smoking and hypercholesterolemia. Biomarkers 2011, 16:405-412.
27. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
28. San Jose G., Fortuno A., Beloqui O., Diez J., Zalba G. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci (Lond) 2008, 114:173-182.